W P Abhayaratna1, T H Marwick, W T Smith, N G Becker. 1. National Centre for Epidemiology and Population Health, Australian National University and Department of Cardiology, The Canberra Hospital, Canberra, ACT, Australia. abhayaratna.walter@mayo.edu
Abstract
OBJECTIVE: To determine the prevalence and predictors of left ventricular (LV) diastolic dysfunction in older adults. DESIGN, SETTING AND PARTICIPANTS: A cross-sectional survey of 1275 randomly selected residents of Canberra, aged 60 to 86 years (mean age 69.4; 50% men), conducted between February 2002 and June 2003. MAIN OUTCOME MEASURES: Prevalence of LV diastolic dysfunction as characterised by comprehensive Doppler echocardiography. RESULTS: The prevalence of any diastolic dysfunction was 34.7% (95% CI 32.1% to 37.4%) and that of moderate to severe diastolic dysfunction was 7.3% (95% CI 5.9% to 8.9%). Of subjects with moderate to severe diastolic dysfunction, 77.4% had an LV ejection fraction (EF) > 50% and 76.3% were in a preclinical stage of disease. Predictors of diastolic dysfunction were higher age (p < 0.0001), reduced EF (p < 0.0001), obesity (p < 0.0001) and a history of hypertension (p < 0.0001), diabetes (p = 0.02) and myocardial infarction (p = 0.003). Moderate to severe diastolic dysfunction with normal EF, although predominantly preclinical, was independently associated with increased LV mass (p < 0.0001), left atrial volume (p < 0.0001), and circulating amino-terminal pro-B-type natriuretic peptide concentrations (p < 0.0001), and with decreased quality of life (p < 0.005). CONCLUSION: Diastolic dysfunction is common in the community and often unaccompanied by overt congestive heart failure. Despite the lack of symptoms, advanced diastolic dysfunction with normal EF is associated with reduced quality of life and structural abnormalities that reflect increased cardiovascular risk.
OBJECTIVE: To determine the prevalence and predictors of left ventricular (LV) diastolic dysfunction in older adults. DESIGN, SETTING AND PARTICIPANTS: A cross-sectional survey of 1275 randomly selected residents of Canberra, aged 60 to 86 years (mean age 69.4; 50% men), conducted between February 2002 and June 2003. MAIN OUTCOME MEASURES: Prevalence of LV diastolic dysfunction as characterised by comprehensive Doppler echocardiography. RESULTS: The prevalence of any diastolic dysfunction was 34.7% (95% CI 32.1% to 37.4%) and that of moderate to severe diastolic dysfunction was 7.3% (95% CI 5.9% to 8.9%). Of subjects with moderate to severe diastolic dysfunction, 77.4% had an LV ejection fraction (EF) > 50% and 76.3% were in a preclinical stage of disease. Predictors of diastolic dysfunction were higher age (p < 0.0001), reduced EF (p < 0.0001), obesity (p < 0.0001) and a history of hypertension (p < 0.0001), diabetes (p = 0.02) and myocardial infarction (p = 0.003). Moderate to severe diastolic dysfunction with normal EF, although predominantly preclinical, was independently associated with increased LV mass (p < 0.0001), left atrial volume (p < 0.0001), and circulating amino-terminal pro-B-type natriuretic peptide concentrations (p < 0.0001), and with decreased quality of life (p < 0.005). CONCLUSION:Diastolic dysfunction is common in the community and often unaccompanied by overt congestive heart failure. Despite the lack of symptoms, advanced diastolic dysfunction with normal EF is associated with reduced quality of life and structural abnormalities that reflect increased cardiovascular risk.
Authors: T S Tsang; M E Barnes; K R Bailey; C L Leibson; S C Montgomery; Y Takemoto; P M Diamond; M A Marra; B J Gersh; D O Wiebers; G W Petty; J B Seward Journal: Mayo Clin Proc Date: 2001-05 Impact factor: 7.616
Authors: R B Devereux; M J Roman; M Paranicas; E T Lee; T K Welty; R R Fabsitz; D Robbins; E R Rhoades; R J Rodeheffer; L D Cowan; B V Howard Journal: Am Heart J Date: 2001-03 Impact factor: 4.749
Authors: John S Gottdiener; Robyn L McClelland; Robert Marshall; Lynn Shemanski; Curt D Furberg; Dalane W Kitzman; Mary Cushman; Joseph Polak; Julius M Gardin; Bernard J Gersh; Gerard P Aurigemma; Teri A Manolio Journal: Ann Intern Med Date: 2002-10-15 Impact factor: 25.391
Authors: J M Gardin; R McClelland; D Kitzman; J A Lima; W Bommer; H S Klopfenstein; N D Wong; V E Smith; J Gottdiener Journal: Am J Cardiol Date: 2001-05-01 Impact factor: 2.778
Authors: Daniel D Correa de Sa; David O Hodge; Joshua P Slusser; Magaret M Redfield; Robert D Simari; John C Burnett; Horng H Chen Journal: Heart Date: 2010-04 Impact factor: 5.994
Authors: Yu Ueda; Catherine T Gunther-Harrington; Christina L Cruzen; Jeffrey A Roberts; Joshua A Stern Journal: J Am Assoc Lab Anim Sci Date: 2017-07-01 Impact factor: 1.232